高氧与抗氧化剂对非心脏手术心肌损伤的影响:2×2析因盲法随机临床试验
该多中心2×2析因随机盲法试验纳入600例>45岁伴心血管危险因素行大非心脏手术患者,比较围术期吸入氧浓度0.80 vs 0.30及抗氧化剂(维生素C 3g静注+ N-乙酰半胱氨酸100mg/kg)vs安慰剂对术后3天内高敏肌钙蛋白曲线下面积的影响。结果显示高氧与抗氧化剂均未改变心肌损伤程度。
要点
- 围术期吸入氧浓度0.80与0.30相比,术后3天心肌损伤程度无差异。
- 抗氧化剂(维生素C+ N-乙酰半胱氨酸)未降低术后3天心肌损伤程度。
- 80%氧吸入未增加30天死亡率,提示该氧浓度在此类手术中安全。
核心结论
- 围术期高吸入氧浓度(0.80)与抗氧化剂干预均未改变大非心脏手术术后3天内的心肌损伤程度。
- 80%氧吸入在此类手术中未显示安全性问题,维生素C与N-乙酰半胱氨酸未见心血管获益。
研究设计与样本
- 2×2析因、随机、盲法、多中心临床试验。
- 纳入年龄>45岁、伴心血管危险因素、行大非心脏手术的患者600例,最终576例纳入主要结局分析。
- 随机分配至吸入氧浓度0.80或0.30组(插管至术后2小时),以及抗氧化剂组(维生素C 3g静注+ N-乙酰半胱氨酸100mg/kg)或安慰剂组。
- 主要结局为术后3天内高敏肌钙蛋白曲线下面积(AUC)评估的心肌损伤程度。
主要发现
- 主要结局(高敏肌钙蛋白AUC)在80%氧组为35 ng·day/l(19-58),30%氧组为35 ng·day/l(17-56)。
- 抗氧化剂组主要结局为35 ng·day/l(19-54),安慰剂组为33 ng·day/l(18-57)。
- 氧组间中位差异为1.5 ng·day/l(95%CI -2.5至5.3;P=0.202)。
- 抗氧化剂组间中位差异为-0.5 ng·day/l(95%CI -4.5至3.0;P=0.228)。
- 30天死亡率576例中9例(1.6%);80% vs 30%氧组OR 2.01(95%CI 0.50-8.1;P=0.329);抗氧化剂 vs 安慰剂OR 0.79(95%CI 0.214-2.99;P=0.732)。
临床怎么用
- 在大非心脏手术中,围术期使用80%吸入氧浓度未增加心肌损伤或30天死亡风险。
- 维生素C与N-乙酰半胱氨酸的抗氧化干预不推荐用于减少此类手术的心肌损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperoxia and oxidative stress may be associated with increased risk of myocardial injury. The authors hypothesized that a perioperative inspiratory oxygen fraction of 0.80 versus 0.30 would increase the degree of myocardial injury within the first 3 days of surgery, and that an antioxidant intervention would reduce degree of myocardial injury versus placebo. METHODS: A 2 × 2 factorial, randomized, blinded, multicenter trial enrolled patients older than 45 yr who had cardiovascular risk factors undergoing major noncardiac surgery. Factorial randomization allocated patients to one of two oxygen interventions from intubation and at 2 h after surgery, as well as antioxidant intervention or matching placebo. Antioxidants were 3 g IV vitamin C and 100 mg/kg N-acetylcysteine. The primary outcome was the degree of myocardial injury assessed by the area under the curve for high-sensitive troponin within the first 3 postoperative days. RESULTS: The authors randomized 600 participants from April 2018 to January 2020 and analyzed 576 patients for the primary outcome. Baseline and intraoperative characteristics did not differ between groups. The primary outcome was 35 ng · day/l (19 to 58) in the 80% oxygen group; 35 ng · day/l (17 to 56) in the 30% oxygen group; 35 ng · day/l (19 to 54) in the antioxidants group; and 33 ng · day/l (18 to 57) in the placebo group. The median difference between oxygen groups was 1.5 ng · day/l (95% CI, -2.5 to 5.3; P = 0.202) and -0.5 ng · day/l (95% CI, -4.5 to 3.0; P = 0.228) between antioxidant groups. Mortality at 30 days occurred in 9 of 576 patients (1.6%; odds ratio, 2.01 [95% CI, 0.50 to 8.1]; P = 0.329 for the 80% vs. 30% oxygen groups; and odds ratio, 0.79 [95% CI, 0.214 to 2.99]; P = 0.732 for the antioxidants vs. placebo groups). CONCLUSIONS: Perioperative interventions with high inspiratory oxygen fraction and antioxidants did not change the degree of myocardial injury within the first 3 days of surgery. This implies safety with 80% oxygen and no cardiovascular benefits of vitamin C and N-acetylcysteine in major noncardiac surgery.
引用
- Holse C, Aasvang EK, Vester-Andersen M, et al. Hyperoxia and Antioxidants for Myocardial Injury in Noncardiac Surgery: A 2 × 2 Factorial, Blinded, Randomized Clinical Trial. Anesthesiology. 2022. PMID: 35120193. doi:10.1097/ALN.0000000000004117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。